The levonorgestrel-releasing intrauterine device induces endometrial decidualisation in women on tamoxifen

References

• Bell SC. 1990. Assessment of endometrial differentiation and function. British Medical Bulletin 46:720–732.
   PubMed Web of Science ®Google Scholar
• Carroll JS, Hickey TE, Tarulli GA, Williams M, Tilley WD. 2017. Deciphering the divergent roles of progestogens in breast cancer. Nature Reviews Cancer 17:54–64.
   PubMed Web of Science ®Google Scholar
• Chan SS, Tam WH, Yeo W, Yu MM, Ng DP, Wong AW, et al. 2007. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. BJOG: An International Journal of Obstetrics & Gynaecology 114:1510–1515.
   PubMed Web of Science ®Google Scholar
• Cohen I, Figer A, Altaras MM, Tepper R, Shapira J, Cordoba M, et al. 1996. Common endometrial decidual reaction in postmenopausal breast cancer patients treated with tamoxifen and progestogens. International Journal of Gynecological Pathology 15:17–22.
   PubMed Web of Science ®Google Scholar
• Cohen I, Shapira J, Altaras M, Cordoba M, Rosen D, Beyth Y. 1992. Endometrial decidual changes in a postmenopausal woman treated with tamoxifen and megestrol acetate. BJOG: An International Journal of Obstetrics and Gynaecology 99:773–774.
   Web of Science ®Google Scholar
• Colletti RB, Roberts JD, Devlin JT, Copeland KC. 1989. Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Research 49:1882–1884.
   PubMed Web of Science ®Google Scholar
• Corley D, Rowe J, Curtis MT, Hogan WM, Noumoff JS, Livolsi VA. 1992. Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstetrics and Gynecology 79:111–116.
   PubMed Web of Science ®Google Scholar
• Critchley HO, Wang H, Jones RL, Kelly RW, Drudy TA, Gebbie AE, et al. 1998a. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery. Human Reproduction 13:1218–1224.
   PubMed Web of Science ®Google Scholar
• Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF. 1998b. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Human Reproduction 13:1210–1217.
   PubMed Web of Science ®Google Scholar
• Dominick S, Hickey M, Chin J, Su HI. 2015. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Cochrane Database Systematic Reviews 12:CD007245.
   Google Scholar
• Early Breast Cancer Trialists' Collaborative Group (EBCTCG), 2005. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717.
   PubMed Web of Science ®Google Scholar
• Fowler DJ, Nicolaides KH, Miell JP. 2000. Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract. Human Reproduction Update 6:495–504.
   PubMed Web of Science ®Google Scholar
• Gardner FJ, Konje JC, Bell SC, Abrams KR, Brown LJ, Taylor DJ, Habiba M. 2009. Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial. Gynecologic Oncology 114:452–456.
   PubMed Web of Science ®Google Scholar
• Hejmadi RK, Chaudhri S, Ganesan R, Rollason TP. 2007. Morphologic changes in the endometrium associated with the use of the mirena coil: a retrospective study of 106 cases. International Journal of Surgical Pathology 15:148–154.
   PubMed Web of Science ®Google Scholar
• Ingec M, Gursoy HG, Yildiz L, Kumtepe Y, Kadanali S. 2004. Serum levels of insulin, IGF-1, and IGFBP-1 in pre-eclampsia and eclampsia. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 84:214–219.
   PubMed Web of Science ®Google Scholar
• Lahteenmaki P, Rauramo I, Backman T. 2000. The levonorgestrel intrauterine system in contraception. Steroids 65:693–697.
   PubMed Web of Science ®Google Scholar
• Lazebnik N, Hill LM, Robinson TM. 1994. Transvaginal sonography in a woman treated with megestrol acetate for breast cancer. Journal of Ultrasound in Medicine 13:652–654.
   PubMed Web of Science ®Google Scholar
• Leao RBF, Andrade L, Vassalo J, Antunes A, Pinto-Neto A, Costa-Paiva L. 2013. Differences in estrogen and progesterone receptor expression in endometrial polyps and atrophic endometrium of postmenopausal women with and without exposure to tamoxifen. Molecular and Clinical Oncology 1:1055–1060.
   PubMedGoogle Scholar
• Leu JI-J, George DL. 2007. Hepatic IGFBP1 is a prosurvival factor that binds to BAK, protects the liver from apoptosis, and antagonizes the proapoptotic actions of p53 at mitochondria. Genes & Development 21:3095–3109.
   PubMed Web of Science ®Google Scholar
• Lonning PE, Hall K, Aakvaag A, Lien EA. 1992. Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients. Cancer Research 52:4719–4723.
   PubMed Web of Science ®Google Scholar
• Nasri MN, Shepherd JH, Setchell ME, Lowe DG, Chard T. 1991. The role of vaginal scan in measurement of endometrial thickness in postmenopausal women. BJOG: An International Journal of Obstetrics & Gynaecology 98:470–475.
   Web of Science ®Google Scholar
• Nuovo MA, Nuovo GJ, Mccaffrey RM, Levine RU, Barron B, Winkler B. 1989. Endometrial polyps in postmenopausal patients receiving tamoxifen. International Journal of Gynecologic Pathology 8:125–131.
   PubMed Web of Science ®Google Scholar
• Pakarinen P, Lahteenmaki P, Rutanen EM. 1999. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1. Acta Obstetricia et Gynecologica Scandinavica 78:423–428.
   PubMed Web of Science ®Google Scholar
• Pengdi Z, Xiaoqun L, Hongzhi L, Zhao G, Jie C, Ruhua X, et al. 1999. The effect of a levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after one year of use. Human Reproduction 14:970–975.
   PubMed Web of Science ®Google Scholar
• Powles TJ, Bourne T, Athanasiou S, Chang J, Grubock K, Ashley S, et al. 1998. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo. British Journal of Cancer 78:272–275.
   PubMed Web of Science ®Google Scholar
• Silverberg SG, Haukkamaa M, Arko H, Nilsson CG, Luukkainen T. 1986. Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices. International Journal of Gynecologic Pathology 5:235–241.
   PubMed Web of Science ®Google Scholar
• Sugita S, Morishita Y, Kano J, Furuya S, Shiba-Ishii A, Noguchi M. 2011. IGFBP-1 is expressed specifically in ovarian clear cell adenocarcinoma. Histopathology 58:729–738.
   PubMed Web of Science ®Google Scholar
• Thierry van Dessel HJ, Chandrasekher Y, Yap OW, Lee PD, Hintz RL, Faessen GH, et al. 1996. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle. The Journal of Clinical Endocrinology & Metabolism 81:1224–1231.
   PubMed Web of Science ®Google Scholar
• Wathen NC, Campbell DJ, Patel B, Touzel R, Chard T. 1993. Dynamics of prolactin in amniotic fluid and extraembryonic coelomic fluid in early human pregnancy. Early Human Development 35:167–172.
   PubMed Web of Science ®Google Scholar